TLDR DocuSign posted Q1 adjusted EPS of $1.09, beating the $1.00 estimate, with revenue of $830.2M vs. $823.23M expected Stock fell ~5% in premarket/after-hoursTLDR DocuSign posted Q1 adjusted EPS of $1.09, beating the $1.00 estimate, with revenue of $830.2M vs. $823.23M expected Stock fell ~5% in premarket/after-hours

DocuSign (DOCU) Stock Drops 5% After Earnings — Here’s Why the Beat Wasn’t Enough

2026/06/05 19:30
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • DocuSign posted Q1 adjusted EPS of $1.09, beating the $1.00 estimate, with revenue of $830.2M vs. $823.23M expected
  • Stock fell ~5% in premarket/after-hours trading despite the beat
  • Q2 revenue guidance midpoint of $867M is barely above the $866M analyst consensus
  • Fiscal 2027 revenue guidance midpoint of $3.496B is only slightly above the $3.49B estimate
  • Jefferies raised its price target to $50 from $45 but kept a Hold rating

DocuSign (DOCU) beat Wall Street on the top and bottom line in Q1, but the stock dropped around 5% after hours as investors found little to get excited about in the company’s forward guidance.


DOCU Stock Card
DocuSign, Inc., DOCU

The stock had climbed 27% from its February low heading into the print, so expectations were running high.

Q1 adjusted EPS came in at $1.09, above the $1.00 consensus. Revenue hit $830.2 million, up 9% year-over-year and ahead of the $823.23 million estimate.

GAAP net income was $0.40 per diluted share, up from $0.34 in the same quarter last year. Non-GAAP gross margin dipped slightly to 81.5% from 82.3% a year earlier.

Free cash flow rose to $289.4 million from $227.8 million a year ago. DocuSign also bought back $317.5 million worth of stock, up sharply from $183.4 million in the prior year period.

Guidance Leaves Little Room for Upside

Q2 revenue guidance came in at $865M–$869M, with a midpoint of $867M — essentially in line with the $866M analyst consensus. Not the kind of raise that moves markets higher.

Full-year fiscal 2027 revenue guidance of $3.49B–$3.502B puts the midpoint just barely above the $3.49B consensus. The implied growth rate, excluding FX, is 7.1%–7.5%.

Dollar Net Retention held flat at 102%, unchanged from the prior quarter — a number analysts are watching closely.

IAM Progress, But Questions Remain

DocuSign’s Intelligent Agreement Management platform now makes up 12.6% of Annual Recurring Revenue, up from 10.8% at the end of January. CEO Allan Thygesen said Q1 saw 40,000 customers investing in the IAM roadmap.

Morgan Stanley acknowledged the solid execution but noted the core debate hasn’t shifted: “IAM traction is improving, yet financial inflection is limited and economics remain too opaque to prove a durable path back to double-digit growth.”

Jefferies raised its price target to $50 from $45 following the revenue beat, but kept its Hold rating intact. The firm noted the stock trades at roughly 10x CY2027 earnings — the lowest multiple in its mid-cap coverage universe.

Enterprise bookings in North America grew at the fastest pace in the quarter, per Jefferies

The post DocuSign (DOCU) Stock Drops 5% After Earnings — Here’s Why the Beat Wasn’t Enough appeared first on CoinCentral.

Market Opportunity
Audiera Logo
Audiera Price(BEAT)
$1.71255
$1.71255$1.71255
-1.40%
USD
Audiera (BEAT) Live Price Chart

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage